Author

Mengying Xia

University of PittsburghPrimary ORCID profile (0009-0006-9298-7667 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Mengying XiaiD1 paper · Sichuan University

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Albert GoughiD· 1 shared Alejandro Soto–GutiérreziD· 1 shared Andrew M. SterniD· 1 shared Celeste E. Reese· 1 shared D. Lansing TayloriD· 1 shared Dillon C. GavlockiD· 1 shared Gregory M LaRocca· 1 shared Iris Plá-Palacín· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Albert GoughORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy

Mengying Xia, Mahboubeh Varmazyad, Iris Plá-Palacín, Dillon C. Gavlock, Richard DeBiasio, Gregory M LaRocca, Celeste E. Reese, Rodrigo Machado Florentino, Lanuza A.P. Faccioli, Jacquelyn Ann Brown, Lawrence A. Vernetti, Mark E. Schurdak, Andrew M. Stern, Albert Gough, Jaideep Behari, , Mark T. Miedel

This study uses a human liver microphysiology system to compare the effects of PNPLA3 variants on MASLD progression and drug response.

Frontiers in Cell and Developmental Biology · Sep 11, 2024Peer-reviewedCell Biology